Intensity Therapeutics (INTS) Return on Equity [ROE] (2023 - 2026)
Intensity Therapeutics (INTS) recorded Return on Equity [ROE] of -116.34% in Q2 2026, up 897.48 percentage points from -1013.82% a year earlier but down 17.09 percentage points from the prior quarter.
Powered by 
Analysis
Intensity Therapeutics (INTS) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Intensity Therapeutics reported Return on Equity [ROE] of -159.42%, up 42.96 percentage points from FY2024.
- Across earlier years, Return on Equity [ROE] came in at -202.38% in FY2024.
- Quarterly Return on Equity [ROE] has ranged from -1013.82% in Q2 2025 to -42.74% in Q3 2023 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has increased for four consecutive quarters, with an average year-over-year change of -23.90 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 897.48 percentage points in Q2 2026, against a drop of 824.32 percentage points in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -99.25% (Q1 2026), -123.50% (Q4 2025) and -253.37% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 22.24% |
| 10 | Intensity Therapeutics | 10.75 Mn | 10.75 Mn | - | -116.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -116.34% |
| Mar 31, 2026 | -99.25% |
| Dec 31, 2025 | -123.50% |
| Sep 30, 2025 | -253.37% |
| Jun 30, 2025 | -1,013.82% |
| Mar 31, 2025 | -925.40% |
| Dec 31, 2024 | -571.21% |
| Sep 30, 2024 | -400.59% |
| Jun 30, 2024 | -200.35% |
| Mar 31, 2024 | -101.07% |
| Dec 31, 2023 | -57.09% |
| Sep 30, 2023 | -42.74% |
API Access
Intensity Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();